People living with this rare blood cancer often deal with complex and unpredictable symptoms. Connecting with support and ...

Myelofibrosis is a rare type of bone marrow cancer. In this condition, extensive scarring (fibrosis) occurs in the bone marrow, which keeps the bone marrow from producing the right number of blood ...

Panelists discuss how myelofibrosis progresses from its molecular and genetic origins through various clinical manifestations ...

Allogeneic hematopoietic stem-cell transplantation is the only curative treatment for myelofibrosis. Driver mutations are the pathophysiological hallmark of the disease, but the role of mutation ...

Myelofibrosis is a rare cancer that affects your bone marrow, the spongy tissue inside some of your bones. In a healthy person, stem cells in the bone marrow make the red blood cells, white blood ...

BACKGROUND: Myelofibrosis is a rare and chronic bone marrow disorder characterized by the abnormal production of blood cells and the development of fibrous tissue in the bone marrow. It falls ...

Allogenic haematopoietic stem cell transplantation (allo-HSCT) can induce bone marrow fibrosis regression in patients with myelofibrosis (MF) however, the effect on the skeleton is unclear.

Opens in a new tab or window Clearance of driver mutations at day 30 after transplantation was associated with a reduced risk of relapse and better survival among patients with myelofibrosis ...

“the challenges of living with myelofibrosis can be burdensome, and symptomatic patients can experience spleen enlargement, fatigue, night sweats, and bone pain.” She added: “The ...

into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.